Cramer: Medicis Pharmaceuticals Looks Attractive
Ockham Research submits:
“Now, for a long time botox, made by Allergan, a stock you know we like, has been synonymous with smooth skin. But now Medicis we’ve likened, MRX as the Pepsi to Allergan’s Coke, has come out with a new treatment called dysport that aims to give botox a run for its money…
Medicis beat Wall Street’s consensus earnings estimates by eight cents per share last quarter and they have serious growth. Then shortly after the quarter on March 10th Medicis boosted its quarterly dividend from 4 cents to 6 cents. I know the yield’s just 1%. But we know dividend hikes are an important sign of strength in a company…
Investing, Long Term Investment, stock market | admin March 16, 2010
RSS feed for comments on this post.
